Sequence‐Specific Primer Polymerase Chain Reaction Genotyping of the Human TLR9 Promoter Polymorphism rs187084 (−1486T>C)
Current Protocols · 2026
DOI: 10.1002/cpz1.70390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, 2026. Verfasst von Guilherme Castellani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Investigation in Dermatology and Immunodeficiencies (LIM-56), Hospital das Clínicas, Faculdade de Medicina da Universidade de S…. Hauptthemen laut MEDLINE: Toll-Like Receptor 9, Promoter Regions, Genetic, Polymorphism, Single Nucleotide, Polymerase Chain Reaction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
This article describes a validated and optimized sequence‐specific primer polymerase chain reaction (PCR‐SSP) protocol for genotyping the human TLR9 promoter polymorphism rs187084 (−1486T>C). Promoter single nucleotide polymorphisms (SNPs) may influence transcriptional regulation and immune signaling. The rs187084 variant has been associated with altered TLR9 expression and susceptibility to infectious, inflammatory, and neoplastic diseases. Although Sanger sequencing provides high analytical accuracy, it is labor‐intensive and costly for large cohorts. TaqMan allelic discrimination assays require fluorescent probes and real‐time PCR instrumentation, increasing cost per sample. High‐resolution melting (HRM) analysis depends on specialized melting platforms and curve interpretation expertise. The PCR‐SSP strategy described here provides a robust and accessible approach based on conventional thermocyclers and standard agarose gel electrophoresis, without the need for specialized instrumentation or probe‐based chemistries. Allele discrimination is achieved using reverse primers differing at the 3′ terminal nucleotide. A 430‐bp human growth hormone ( HGH ) fragment is co‐amplified as internal control. Optimization of MgCl 2 concentration, primer ratios, and annealing temperature ensured specificity, sensitivity, and reproducibility. This protocol is suitable for genetic association studies and population‐based analyses of TLR9 rs187084. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol : PCR‐SSP genotyping of TLR9 rs187084 Support Protocol : Genomic DNA extraction from whole blood by the salting‐out method
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medical Investigation in Dermatology and Immunodeficiencies (LIM-56), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), University of São Paulo, São Paulo, Brazil.
- Department of Basic Health Sciences (DBS), Laboratory of Immunogenetics (Imunogen-UEM), State University of Maringá, Maringá, Brazil.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Castellani, G., Massi, F. P., Yamanaka, A. H. U., Neto, Q. A. L., & Pinto, L. D. B. (2026). Sequence‐Specific Primer Polymerase Chain Reaction Genotyping of the Human TLR9 Promoter Polymorphism rs187084 (−1486T>C). Current Protocols. https://doi.org/10.1002/cpz1.70390
Vancouver
Castellani G, Massi FP, Yamanaka AHU, Neto QAL, Pinto LDB. Sequence‐Specific Primer Polymerase Chain Reaction Genotyping of the Human TLR9 Promoter Polymorphism rs187084 (−1486T>C). Current Protocols. 2026. doi:10.1002/cpz1.70390
BibTeX
@article{Castellani2026,
author = {Castellani, Guilherme and Massi, Fernanda Pelisson and Yamanaka, Aléia Harumi Uchibaba and Neto, Quirino Alves de Lima and Pinto, Larissa Danielle Bahls},
title = {Sequence‐Specific Primer Polymerase Chain Reaction Genotyping of the Human TLR9 Promoter Polymorphism rs187084 (−1486T>C)},
journal = {Current Protocols},
year = {2026},
doi = {10.1002/cpz1.70390}
}
EUVIMED